- authorisedHuman Pharmacology (Phase I)- First administration to humans
OPEN-LABEL, PHASE I CLINICAL TRIAL TO EVALUATE THE SAFETY AND PRELIMINARY CLINICAL RESPONSE TO THE USE OF ALLOGENEIC BONE MARROW MESENCHYMAL STEM CELLS IN CHILDREN AND ADOLESCENTS WITH X-LINKED ADRENOLEUKODYSTROPHY CEREBRAL FORM.
This early-stage study is testing a new stem cell treatment for boys and young men with cerebral adrenoleukodystrophy (ALD). Researchers want to see if cells taken from healthy bone marrow are safe, well-tolerated, and able to help slow down damage to the brain caused by this rare condition.
Spain - recruitingHuman Pharmacology (Phase I)- Other
A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EFFECT ON ORAL LERIGLITAZONE IN MALE HEALTHY SUBJECTS
This study is looking at how a new drug, leriglitazone, behaves in the body of healthy men. It checks if other common medicines or food affect how leriglitazone works. This helps us understand its safety and effectiveness for conditions like Adrenoleukodystrophy.
Poland